IP Library › Granted Patent US 12,281,239
Granted Patent B2
US 12,281,239 · App. 18/442,515 · Granted Apr 22, 2025

Antimicrobial additive compositions for coatings

Inventor: Okan Demir (Istanbul, TR)
Assignee: PEGASUS ENVIRONMENTAL RESEARCH AND INVESTMENT GROUP LLC
C09D5/14C08K3/015C08K3/38C08K5/0058C08K5/0091C08K5/19C09D5/16C09D5/1606C09D5/1612C09D5/1618C09D5/1625C09D5/1687C08K2003/387
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,281,239
App. No.
18/442,515
Granted
Apr 22, 2025
Kind
B2
Abstract

An antimicrobial formulation that can be directly added into a composition or onto a surface of a composition (e.g., forming a surface coating on a composition or device). The antimicrobial formulation includes sodium pentaborate, di-sodium tetraborate decahydrate, titanium diborite, titanium borate, sodium pyrithione, zinc pyrithione, benzhetonium chloride, or any combination thereof.

Claims (16)

1. A paint comprising:

an antimicrobial formulation, the antimicrobial formulation comprising,

di-sodium tetraborate decahydrate at a concentration ranging from 1 wt % to 20 wt %,

zinc pyrithione and/or sodium pyrithione at a concentration ranging from 0.005 wt % to 10 wt %, and

benzethonium chloride at a concentration ranging from 0.01 wt % to 10 wt %.

2. The paint of claim 1 , wherein the antimicrobial formulation further comprises sodium pentaborate at a concentration ranging from 1 wt % to 20 wt %.

3. The paint of claim 1 , wherein the antimicrobial formulation further comprises titanium diboride at a concentration ranging from 0.2 wt % to 20 wt %.

4. The paint of claim 1 , wherein the antimicrobial formulation further comprises titanium borate at a concentration ranging from 0.2 wt % to 20 wt %.

5. The paint of claim 1 , wherein the antimicrobial formulation further comprises sodium pyrithione at a concentration ranging from 0.001 wt % to 10 wt %.

6. The paint of claim 1 , wherein the antimicrobial formulation further comprises at least one of sodium pentaborate, titanium diboride, titanium borate, or sodium pyrithione.

7. The paint of claim 1 , wherein the antimicrobial formulation further comprises at least two of sodium pentaborate, titanium diboride, titanium borate, or sodium pyrithione.

8. The paint of claim 1 , wherein the antimicrobial formulation further comprises at least three of sodium pentaborate, titanium diboride, titanium borate, or sodium pyrithione.

9. The paint of claim 1 , wherein the antimicrobial formulation further comprises each of sodium pentaborate, titanium diboride, titanium borate, or sodium pyrithione.

10. The paint of claim 1 , wherein the antimicrobial formulation reduces antimicrobial activity of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae , Methicillin-resistant Staphylococcus aureus (MRSA), Salmonella typhi , Vancomycin-resistant Enterococcus (VRE) when contacted therewith.

11. The paint of claim 1 , wherein the antimicrobial formulation further comprises antifungal activity in which the formulation reduces Candida albicans activity.

12. The paint of claim 1 , wherein the paint is a non-aerosol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2024
From: DEMIR, OKAN; SANLIER, BENAN; KAZBOUR, JAMAL
To: PEGASUS ENVIRONMENTAL RESEARCH AND INVESTMENT GROUP LLC
Reel/Frame 067217/0418 →
Continuity (3)
Continuation 17193521 · Mar 5, 2021
Provisional Application 62986950 · Mar 9, 2020
Related Publication 20240301217A1 · Sep 12, 2024
References Cited (10)
US 6750276B2 · Ruggiero et al. · 2004 [cited by applicant]
US 9763453B2 · Cook et al. · 2017 [cited by applicant]
US 11123432B2 · Sahin et al. · 2021 [cited by applicant]
US 11905435B2 · Demir · 2024 [cited by examiner]
US 20080118734A1 · Goodwin et al. · 2008 [cited by applicant]
US 20180244895A1 · Iyigundogdu et al. · 2018 [cited by applicant]
US 20180296737A1 · Sivakumaran et al. · 2018 [cited by applicant]
US 20200100995A1 · Sangirardi et al. · 2020 [cited by applicant]
ES 2426216T3 · 2013 [cited by applicant]
WO 2019115172A1 · 2019 [cited by applicant]